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Lymphocytic choriomeningitis has been shown to belong to  the group 
of virus diseases which is characterized by the occurrence in infected tissues 
of a  soluble antigen separable from the virus (1,  2).  The presence of the 
specific soluble antigen of lymphocytic choriomeningitis was demonstrated 
in extracts of various organs of acutely ill guinea pigs, mice, and monkeys 
by means of complement fixation (2).  In addition, certain characteristics 
of the antigen have been determined (3).  Moreover, the soluble antigen 
has been found to be  capable  of absorbing  complement-fixing antibodies 
from immune serum without appreciably affecting the neutralizing power 
of the serum (3), an observation which suggested that the anti-soluble sub- 
stance  antibodies  are  independent  of  the  neutralizing  antibodies.  The 
present report deals with evidence of another type which indicates that the 
two antibodies are separate entities. 
In a previous publication (3) the use of the terms anti-soluble substance 
antibody and complement-fixing antibody as synonymous expressions ap- 
peared to be justified by the evidence mentioned and by the fact that prac- 
tically all of the fixing power of a  crude suspension of infected tissue was 
demonstrable in the non-infectious portion containing the soluble antigen 
rather than in the preparation of washed virus sedimented from the crude 
material (2).  Although a  number of reports have dealt with complement 
fixation in  lymphocytic choriomeningitis, most of them have not distin- 
guished between the r61e of the soluble antigen and that of the infective 
agent.  Since we wish at this time to discuss the antibodies which appear 
in  man  and  in  a  number of  animal species following infection with  the 
virus  of  lymphocytic choriomeningitis, a  summary  of  previous  findings 
seems called for. 
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Armstrong and Lillie  (4)  in 1934 described a  virus which they encountered during 
passage through monkeys of an agent considered to be the virus of St. Louis encephalitis; 
this new virus was named lymphocytic choriomeningitis.  At that time they reported 
the occurrence of neutralizing antibodies in the serum of convalescent monkeys.  Shortly 
afterward Armstrong and Wooley (5)  detected neutralizing antibodies in the serum of 
3 human beings, and Rivers and Scott (6, 7) demonstrated the development of neutraliz- 
ing substances  in the first  human beings from whom the virus was isolated directly. 
The latter workers also reported the occurrence of this type of antibody in convalescent 
monkeys.  The appearance  of protective substances  in the  serum of patients  during 
convalescence was immediately confirmed by Armstrong and Dickens (8) and has been 
repeatedly shown since that time.  Moreover, L6pine, Mollaret, and Kreis (9) demon- 
strated the development of these antibodies in human beings inoculated with a murine 
strain of virus for therapeutic purposes.  Neutralizing substances appeared both in the 
patients who developed meningitis and in those who had only an influenza-like  disease 
without later signs of meningeal irritation.  Protective substances have also been found 
in about 12 per cent of the sera from 997 individuals from various parts of the United 
States without history of involvement of the central nervous system (10) and in 18 per 
cent of the sera obtained from a  widely scattered group of 680 persons in the United 
States and Hawaii, a number of whom had previously suffered from disease of the central 
nervous system (11). 
Neutralizing antibodies have been detected in several other species of animals fol- 
lowing  inoculation  of  the virus  of lymphocytic choriomeningitis.  Rivers  and  Scott 
(6 a)  and Traub  (12)  reported  the presence of protective substances in  the serum of 
guinea pigs after recovery from the induced disease.  Certain species which fail to show 
clinical  evidence of disease  after inoculation with  the  virus  do nevertheless  develop 
neutralizing antibodies.  For example, rabbits  (4, 6, 13, 14),  dogs (15-17), and ferrets 
and pigs  (16)  are refractory to infection, yet each of these species has been found to 
possess protective substances subsequent to inoculation (13 b, 14-17).  Mice appear to 
be an exception to the rule, since Traub (12) and Tranb and Sharer (18) have observed 
that  these rodents do not possess demonstrable neutralizing antibodies in their serum 
even when they are immune to reinfection. 
Howitt (19) was the first to report complement fixation in the presence of mixtures of 
hyperimmune serum from guinea pigs or mice and extracts of infected guinea pig tissue. 
L~pine and Sautter  (20)  obtained complement fixation with serum from an individual 
who accidentally contracted the disease in the laboratory.  Shortly afterward,  L6pine 
and his associates  (21)  reported positive reactions with sera from the previously men- 
tioned group of inoculated human beings (9) and from other patients during convales- 
cence as well as with serum from inoculated monkeys and rabbits; however, they did not 
detect complement-fixing antibodies in the serum of infected guinea pigs.  L6pine and 
his coworkers, like Howitt, used a  crude extract of infected tissue as antigen.  About 
this time experiments reported by us (1) showed that anti-soluble substance antibodies 
develop after infection in man and guinea pigs and are responsible for complement fixa- 
tion.  Subsequently, work elsewhere and in our laboratory confirmed Howitt's original 
report  that  serum from hyperimmune mice fixes  complement with preparations  from 
infected tissue; crude tissue extracts (18, 22) and soluble antigen (23) were employed. 
The  present  report  describes  results  of  investigations  on  the  time  of 
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stances in man  and  several species of lower animals.  In addition,  experi- 
ments  concerning  the  immunization  of  guinea  pigs  with  non-infectious 
material are recorded. 
Materials and Methods 
Antisera.--Simple  immune sera were obtained from animals under light ether anes- 
thesia by intracardiac puncture at various intervals of time after inoculation with a mild 
strain of the virus of lymphocytic choriomeningitis. 
Soluble Antigen.--Solutions  of antigen were prepared according to the method de- 
scribed in a previous report (2).  A 10 per cent suspension of infected guinea pig spleen 
was made in physiological  saline solution containing 2 per cent inactivated normal guinea 
pig  serum.  After  the material was freed of coarse particles by means of a  horizontal 
centrifuge, it was cleared of most of the virus by a run in a concentration centrifuge (24) 
at 30,000 I~.I,.M.  for 20 minutes; it was then filtered through a Seitz pad which reduced the 
infectivity to a few units per cc.  In order to maintain bacteriological sterility, merthi- 
olate was  added to a  concentration  of  1:10,000.  Extracts  of infected mouse  spleen 
prepared by a similar method were employed in a few instances. 
Complement-Fixagion Tea.--The technique of the complement-fixation test used for 
the detection of anti-soluble substance antibodies was the same as has been previously 
described (2).  Its salient features are the following: 0.2 cc. each of varying dilutions of 
inactivated serum were mixed with an equal amount of appropriately diluted solution 
of antigen; 2 units and in some instances 5 units of antigen which had previously been 
standardized with hyperimmune guinea pig serum were employed.  Following the addi- 
tion of 2  units of complement, the mixtures were allowed to stand overnight at 3°C. 
The next morning 0.5 cc. of a  5 per cent suspension of washed sheep erythrocytes and 
0.2 cc. of diluted anti-sheep cell amboceptor (2 units of hemolysin) were added to each 
tube.  The degree of hemolysis was finally estimated after the tubes had been left in a 
water bath at 37°C. for 30 minutes.  Suitable anticomplementary and hemolytic con- 
trols for each material to be tested were always included.  The titer of the serum was 
regarded as the highest dilution which fixed complement completely in the presence of 
soluble antigen.  A positive guinea pig serum of known titer was run as a  control for 
each group of tests. 
Neutraliza2ion Test.--The test for the determination of the presence of neutralizing 
antibodies in serum was performed according to the technique devised by Muench and 
Scott  I and used in this laboratory (25)  for  several years.  Briefly it consisted of the 
subcutaneous inoculation of 4 young normal guinea pigs, weighing 300 to 350 gm. each, 
with 0.5 cc. of a mixture of equal parts of the serum to be tested and of a  10 -8 dilution 
of fresh brain from guinea pigs infected with the W. E. strain of virus.  The mixture was 
incubated in a water bath at 37°C. for 1 hour immediately before injection.  Adequate 
positive and negative controls were included.  Daily observations as well as the recording 
of temperatures were made for 18 days.  The test was considered positive if at least 
3 guinea pigs survived, negative if 3 succumbed, and equivocal if 2 died; as a  rule, all 
animals in a group responded in a  similar manner. 
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EXPERIMENTAL 
Development of Anti-Soluble  Substa~e Antibodies and Neutralizing 
Antibodies in Man after Infection with the Virus 
At  the  beginning  of  the  present  work  there  existed  in  our  laboratory 
a number of specimens of serum collected from positive cases of lymphocytic 
choriomeningitis (7, 25), as well as numerous samples which were considered 
to be from negative  cases inasmuch  as they did not neutralize  the  virus. 
We were interested  in  determining  how many  of these  sera were capable 
of binding complement in the presence of a solution of antigen; accordingly, 
all  available  specimens  were  tested.  Although  many  were  found  to  be 
anticomplementary  after their  long period of storage,  specimens of serum 
from 4  of the  patients  with lymphocytic choriomeningitis  were shown  to 
contain anti-soluble substance antibodies.  During the past 2½ years sero- 
logical  studies have been performed  on material  from  12  additional  cases 
of  lymphocytic  choriomeningitis  and  from  55  patients  who  had  aseptic 
meningitis of unknown etiology.  2  None of the latter group developed anti- 
soluble  substance  antibodies;  moreover,  convalescent  serum  from  26  of 
these individuals did not contain protective substances. 
Results of complement-fixation  and  neutralization  tests  on  serum  from 
16 human beings who suffered from lymphocytic choriomeningitis are sum- 
marized  in  Table  I.  Serum  taken  1 to 5 weeks after  onset  of  meningitis 
from  11 patients  gave a  positive complement-fixation reaction.  Only two 
(R. R. and J. V.) of these specimens, however, possessed definite neutraliz- 
ing ability at  this  time.  Serum obtained at a later date from 4  additional 
patients  also fixed  complement;  thus,  15  of  the  16  persons  had  demon- 
strable  anti-soluble  substance  antibodies.  A  second  specimen  was  not 
available from I  of the group, but the remaining  15  individuals  developed 
neutralizing antibodies following recovery from the disease.  It appears that 
anti-soluble  substance  antibodies generally  develop  several  weeks  earlier 
than neutralizing antibodies, that they are still detectable when neutralizing 
substances  have  developed,  and  that  they  disappear  while  neutralizing 
antibodies  are  still present;  the latter,  which usually appear  6 to 8  weeks 
after  onset  of  illness,  may  persist  for  at  least  5  years  after  a  patient's 
recovery from  the  disease. 
An exception to the rule is illustrated  in Table I  by the case of D.  S. ; 
although he was proved to have lymphocytic choriomeningitis by neutraliza- 
tion studies, complement-fixing antibodies were not detected in any of the 
samples of his serum, i.e., those collected at 2, 6, and 12 weeks after onset. 
2 Specimens of serum from these 67 individuals were sent to us by physicians prac- 
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This individual is the only one we have encountered in whom a discrepancy 
occurred  in  the diagnostic data  obtained by the  complement-fixation  and 
neutralization  techniques.  Whether  D.  S.  ever  possessed  complement- 
fixing antibodies or whether they were present in small amounts for a brief 
interval  of  time  when  blood  was  not  taken  is  unknown.  Complement- 
fixing  antibodies may decline  rapidly  as illustrated  in  the  case of S.  M.; 
TABLE  I 
Development  of Anti-Soluble  Substance  Antibodies  and Neutralizing  Substances  in Serum 
of Patients with Lymphocytic Choriomeningitis 
Patient 
W. E. (7) 
R. E. S. (7) 
B. s. (25) 
R. R. (25) 
M.S. 
M.W. 
A.S. 
R.Z. 
E.P. 
W.D. 
Onset  of 
meningitis 
Dec., 1934 
Aug., 1936 
Mar., 1937 
Oct.  " 
Dec.  " 
Nov., 1938 
May, 1939 
Oct.  " 
Nov.  " 
W.P. 
D.S. 
K.P. 
J.V. 
J.P. 
S.M. 
Dec.  " 
~t  tt 
tt  tt 
Apr., 1940 
II  gg 
May  " 
Early  serum 
Time 
C-F*  Nt  after 
onset 
Wk$ • 
+  -  3 
+  -  3 
No specimen 
+  +  3 
+  -  5 
¶  -  1 
No specimen 
+  [  ±  4 
+  ]  -  1 
+  i  -  3½ 
i 
--  !  --  2 
+  --  2 
+  +  5 
-4-  --  3 
--  1 
3 
t 
Convalescent  serum 
~-F  N 
+  + 
+  + 
+  +  2 
+  +  2 
+  +  2 
No specimen 
+  +  3 
+  +  4 
+  +  1 
+  +  2 
No specimen 
--  +  3 
--  +  5½ 
+  +  1½ 
+  +  2 
+  +  1½ 
Time 
after 
onset 
~$. 
4 
3 
Late  serum 
Time 
C-F  N  after 
onset 
yf$. 
-  +  5 
-  +  4 
-  +  2½ 
-  +  1½ 
-  +  1 
* C-F  =  complement-fixation test. 
t  N  =  neutralization test. 
¶  Serum anticomplementary. 
serum taken 3 weeks after onset of disease titered 1 : 8,  whereas a specimen 
drawn 4 days later titered  1:4.  Results with both sera were reproducible. 
In  our  experience,  the  complement-fixing  titer  in  man  has  never  gone 
above 1:32  although higher  titers do occasionally occur (21). 
Development of Antibodies in Species Other than Man after 
Infection with the Virus 
Guinea  Pigs.--The  development of complement-fixing  and  neutralizing 
antibodies  was followed in  groups  of guinea  pigs  subsequent  to infection 
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Experiment 1.--10 guinea pigs weighing 300 to 350 gin. each were bled by intracardiac 
puncture while under ether anesthesia.  Their sera when tested individually contained 
neither anti-soluble substance antibodies nor neutralizing properties.  Each animal was 
inoculated with subcutaneous and intraperitoneal injections of 0.5 cc. and 1.0 cc.,  re- 
spectively, of a 10 per cent suspension  of fresh brain from guinea pigs infected with the 
W. W. S. strain of virus; this strain is of low virulence and seldom kills guinea pigs.  3 to 
5 days after inoculation all of the pigs developed a slight amount of fever which persisted 
for several days, but none of them manifested other signs of disease.  Animals were bled 
at intervals from 2 to 32 weeks after inoculation of virus and their sera were tested for 
the presence of anti-soluble substance antibodies and for the property of neutralizing 
TABLE  II 
Development of Anti-Soluble Substance Antibodies and Ne~ralizing Substances in Guinea 
Pigs after Infection witk the W. W. S. Strain of Virus 
"~  Test 
befo] 
info 
1 
2 
3 
4 
5 
6 
2  4 
C-F  N  C-F 
1:32--1:64 
1:16 -- 1:32 
1:64  1:128 
1:64--1:64 
1:16--1:32 
1:32--1:64 
Tests after infection 
Interval after infection (weeks) 
5  6  8 
N  C-F  N  C-F  N  C-F[ 
I 
--  1:54  1:54' 
--1:64  --1:128  +  D 
1:512  1:128 4- 1:54 
--  1:54  --  1:54 
--1:54  --1:128"--1:54 
--1:128+1:256  +1:64 
lO  13 
N  C-F  N  C-F 
+  1:54  D 
+  1:128  1:128 
+1:128  i1:32 
-F 1:54  +  1:32 
1:128 +  1:128 
20  27  32 
N  C-F  N  C-F  N  C-F  N 
~1:~  1:64  D 
1:32 +  1:32  1:4  + 
1D2 +li:54  1:8" + 
D  indicates death following cardiac puncture. 
See text for details of experiment. 
* Partial fixation of complement at this dilution. 
virus.  4 of the 10 animals died during the first month of the experiment as a result of 
hemorrhage caused by cardiac puncture.  Data obtained on these animals before death 
were in complete agreement with those on the other 6 animals; consequently these 4 pigs 
need no further discussion. 
From  the  results  of this  experiment,  shown  in  Table  II, it is  apparent 
that anti-soluble substance antibodies were present in the serum of guinea 
pigs 2 weeks after inoculation of the virus and that, in general, they reached 
their highest concentration  5  to 6 weeks after infection; subsequently they 
gradually declined to a low titer 32 weeks after infection.  It is also evident 
that neutralizing antibodies did not appear until 5 to 8 weeks after inocula- 
tion  and  that  these substances were still detectable at 32 weeks.  A  com- 
parison  of the  time of appearance of the  2  types of antibody reveals that 
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of  anti-soluble  substance  antibodies  were  greatest.  The  neutralizing 
power of serum bore no quantitative relationship, however, to the titer of 
anti-soluble substance antibodies.  This is shown by the fact that toward 
the end of the experiment the serum still neutralized the virus even though 
complement-fixing antibodies had dropped to a titer as low as or even lower 
than that observed during the first weeks after infection. 
Experiment 2.--A similar experiment was carried out with a group of 5 guinea pigs 
infected subcutaneously  with 0.2 cc. of a 5 per cent suspension of the R. E. S. strain of 
virus.  Although  guinea pigs usually survive a subcutaneous inoculation of the R. E. S. 
strain, the resultant disease is more severe than that encountered in infection with the 
TABLE  ni 
Development of Anti-Soluble Substance Antibodies and Neutralizing  Substances in Guinea 
Pigs after Infection  with the R. E. S. Strain of Virus 
Guinea 
11 
12 
13 
14 
15 
2 
C-F!  N  c-F 
i  --  .  _  1:2~ 
1:2' 
I 
Tests  after infection 
Interval after infection  (weeks) 
N 
4 
C-F  N 
1:64  -- 
1:32  -- 
1:64  -- 
1:32  -- 
1:32  -- 
6 
C-F 
1 : 128 
1:256 
1:128 
1:16 
!1:64 
8  12 
N  C-F  N  C-F 
+i:16  +I:12~ 
--1:64'  +1:64 
+1:64"  +1:12~ 
--  1:16  --  1:4 
4- 1:16  +1:32 
2o 
N  C-F 
+1:64 
~  1:128 
1:128  ;° 
1:64 
25 
N  C-F 
1:32 
1 : 128 
1:64 
1:64 
29 
N  C-F  N 
1:32  q- 
1:64  -~ 
1:32  -~ 
1:64  ~- 
D indicates death following  cardiac puncture. 
See text for details of experiment. 
* Partial fixation of complement at this dilution. 
W. W. S. strain of virus.  The animals developed  fever which  in most instances  persisted 
for 2 weeks, during which time they lost weight; however, all of them recovered. 
Data on guinea pigs infected with the R. E. S. strain of virus, summarized 
in  Table  III,  show a  slower  development of both  anti-soluble  substance 
antibodies and neutralizing substances than was observed in Experiment 1. 
The former were either absent or present in very small amounts 2  weeks 
after infection, but were demonstrable in moderate amounts at 4 weeks, with 
a peak occurring at about 6 weeks.  8 weeks after inoculation neutralizing 
antibodies had appeared in the serum of 4 of the 5 animals and 4 weeks later 
were  demonstrable in  the  serum  of the  remaining pig.  The  slightly re- 
tarded formation of antibodies may have been dependent upon the severity 
of the disease suffered by the animals.  In general, the results obtained with 
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1, i.e., complement-fixing antibodies appeared before neutralizing substances 
and  decreased  significantly in  amount  while  the  latter  were  still  present. 
It should be pointed out at this time that not all strains of the virus of 
lymphocytic choriomeningitis induce an  antibody response in  guinea pigs 
similar to that described.  Certain strains,  e.g.,  the highly virulent W.  E. 
strain, invariably kill inoculated guinea pigs before demonstrable antibodies 
appear in their serum.  This is true even when high dilutions of infectious 
material are inoculated; in such instances,  either infection occurs followed 
by death  or no disease  ensues leaving  the  animals  without  antibodies  or 
immunity. 
Mice.--It  was  regularly demonstrated  that  serum  obtained  from  mice 
after  infection  with  the  virus  of  lymphocytic choriomeningitis  possessed 
anti-soluble  substance antibodies.  Such serum,  however, did not contain 
demonstrable  neutralizing antibodies. 
In one typical experiment, each of 50  young Swiss mice was inoculated intraperi- 
tone.ally with 0.5 cc. of a  10 per cent suspension of guinea pig brain infected with the 
W. E. strain of virus.  At various intervals of time after infection, a  few mice were 
anesthetized and  then  exsanguinated by  intracardiac puncture.  About  half  of  the 
animals died 6 to 7 days after inoculation as a result of infection.  A few of the survivors 
still appeared ill as late as the  17th day after inoculation,  but neither whole blood nor 
suspensions of spleen taken at this time or 4 weeks later were infectious for normal mice. 
Extracts of spleens prepared from mice of these 2 groups,  i.e., at 17 days and 6 weeks, 
did not contain demonstrable soluble antigen, although such extracts regularly contain 
the antigen when prepared from ill mice sacrificed at 6 to 7 days (2). 
Anti-soluble substance antibodies in pooled serum taken from groups of mice sacrificed 
at 8 days titered 1:8; at 10, 13, and 17 days, respectively, 1:64; at 6 weeks 1:32; at 10 
weeks  1:32.  Pooled normal mouse serum failed to fix complement with the antigen 
employed, i.e., extracts of infected mouse spleen.  Sera collected at 17 days, 6 weeks, 
and 10 weeks after infection were unable to neutralize the virus. 
Monkeys.--During  the course of the present work it was  observed that 
monkeys  also  develop  anti-soluble  substance  antibodies  after  infection. 
In  1938, Dr. Lowell T. Coggeshall of the International Health Division of 
The Rockefeller Foundation encountered an epizootic disease in his colony 
of monkeys (26), the infectious agent of which was shown by Dr. Thomas 
Francis,  Jr.,  to  be  the  virus  of  lymphocytic choriomeningitis  (26).  Dr. 
Coggeshall has  allowed us to include in this  report the results of comple- 
ment-fixation tests on samples of serum collected from several animals be- 
fore and after the epizootic.  Observations on specimens from one animal 
are illustrative of the group. 
8 samples of serum which were obtained from a monkey over a period of about 14 
months were tested.  Fortunately, there were 2 specimens from this animal which served J'.  E.  SMADEL  AND  M.  J.  WALL  397 
as suitable controls, inasmuch as they were obtained before the epizootic and contained 
no demonstrable complement-fixing antibodies.  A mildly positive reaction (titer, 1:8) 
was obtained with the third specimen taken shortly after the onset of the disease, while 
serum taken 4 weeks later titered 1:512.  21, 37, and 42 weeks after the first positive 
specimen, the titer of the serum was 1 : 128 in each instance.  At 44 weeks the monkey 
succumbed to tuberculosis; a neutralization test performed by Dr. Coggeshall on serum 
taken prior to death revealed that it possessed ability to protect against the W. E. strain 
of virus.  Our neutralization test on this specimen confirmed his finding.  It has been 
our experience that convalescent sera stored in a native state quickly lose their neutraliz- 
ing power but if dried from the frozen state they remain potent for at least 4 years. 
Since the earlier specimens had been stored in a native state for several months, neutral- 
ization tests were not performed with them. 
Rabbits.--Anti-soluble  substance  antibodies  were  shown  to  develop  in 
rabbits  after injections  of virus-infected  material,  although  these  animals 
do not  develop clinical  signs  of disease.  Even nursing  rabbits,  in  our ex- 
perience, do not appear ill after intracerebral injection of active virus; such 
rabbits, however, are retarded in growth for several weeks when compared 
with uninoculated  animals of the same litter and, in some instances,  slight 
lesions are found in the meninges and choroid plexus. 
2 adult rabbits whose sera did not contain complement-fixing antibodies were injected 
intraperitoneally with 2 cc. each of a 10 per cent suspension  of infected guinea pig brain. 
The animals remained afebrile and in all respects were asymptomatic for the  18 day 
period of observation.  At various intervals of time after receiving the virus, they were 
bled from the marginal vein in the  ear for samples of serum.  Before being used each 
serum was absorbed with packed, washed sheep erythrocytes in order to remove the 
sheep cell hemolysins which  were present.  Such absorption did not appreciably alter 
the complement-fixing titer of the serum. 
Anti-soluble substance antibodies, which were present in small amounts 11 days after 
injection of virus (titer, 1:4 to 1:8), reached a peak about the 4th week (titer, 1:64 to 
1 : 128), and had subsided considerably by the 6th week after injection (titer, 1 : 8 to 1 : 16). 
Sera collected at 4, 6, and 12 weeks after inoculation were tested for neutralizing anti- 
bodies; at 4 weeks one sample was negative, while the other was positive; at 6 and 12 
weeks both were positive.  A specimen of serum taken from a nursing rabbit 2 weeks 
after intracerebral inoculation of the W. E. strain of virus was found to fix complement 
in a dilution of 1:32. 
Response of Normal Guinea Pigs to Injections  of Soluble A ntigen and 
Inactivated  Virus 
It became of interest  to determine  whether  anti-soluble  substance  anti- 
bodies appeared  only after infection with  the  virus or whether  they could 
be elicited by injections of soluble antigen or by inactivated virus. 
Attempts were made to immunize normal guinea pigs with preparations 
of complement-fixing antigen freed of active virus.  For this purpose solu- 398  ANTIBODIES  OF  LYMPHOCYTIC  CHORIOM~ENINGITIS 
tions of antigen prepared according to routine could not be employed be- 
cause of the presence in them of small amounts of active virus; 0.03  cc. of 
undiluted  antigen  inoculated  intracerebrally  into  mice  were  often  non- 
infectious, but  2  cc.  given intraperitoneally to guinea pigs frequently re- 
sulted in death.  The slight infectivity of the solutions of antigen could be 
eliminated by heating them at 56°C. for 30 minutes or by treatment with 1 
per cent formaldehyde, procedures which did not reduce the  complement- 
fixing power  of  the  solution.  Attempts  at  immunization were  entirely 
unsuccessful when non-infectious preparations of soluble antigen were  em- 
ployed.  Only one experiment need be cited. 
Each of 6 guinea pigs was injected intraperitoneally with a total of 12 to 15 cc. of a 
formolized solution of antigen (C-F titer, 1  : 16) over a period of 4 to 5 weeks.  Neither 
complement-fixing  nor neutralizing antibodies were demonstrable 1 to 2 weeks fonowing 
the last injection.  Furthermore,  all of the animals developed fever and succumbed 
when given a standard dose  s of virus.  The results of observations on these 6 animals 
are included in Table IV. 
The  immunizing properties  of  heat-inactivated  suspensions  of  splenic 
virus which had been  washed by differential sedimentation in  the  ultra- 
centrifuge  were  next  investigated.  Suspensions  of  washed  virus  were 
highly virulent for mice and guinea pigs; 0.03 cc. of a 10  --7 dilution were as a 
rule lethal for mice when given intracerebrally, and 0.15  cc. of a  10  -s dilu- 
tion injected by the same route killed guinea pigs.  1 cc. doses of washed 
virus which had been inactivated by heating at 56°C. for 1 hour were in- 
jected intraperitoneally into each of 4 guinea pigs at weekly intervals for 6 
weeks.  None of the animals developed complement-fixing or neutralizing 
antibodies, and none of them survived a  test dose  s of active virus. 
Traub (27) has reported the immunization of guinea pigs by the injection 
of formolized suspensions of tissues infected with the virus of lymphocytic 
choriomeningitis.  Inasmuch as the method of inactivation of suspensions 
of pneumococci (28) has been shown to have a bearing on their effectiveness 
in inducing resistance in animals receiving them, an attempt was under- 
taken to immunize guinea pigs with suspensions of washed virus inactivated 
by formalin instead of heat. 
Spleens which had been removed from 30 moribund guinea pigs inoculated 6 days 
previously with the W. E. strain of virus, and then stored in the frozen state at -10°C. 
s A standard dose of virus consisted of 0.5 cc. of a mixture of equal parts of normal 
guinea pig serum and of a 10  -3 dilution of guinea pig brain infected with the W. E. strain 
of virus.  The mixture was inoculated subcutaneously immediately after being heated 
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for 2 weeks, were thawed and treated in the routine manner for the preparation of soluble 
antigen and washed virus (2).  The solution of antigen from these organs was formolized 
and used for the immunization of the normal guinea pigs mentioned earlier.  The sus- 
pension of washed virus which was infective for mice in a dilution of 10  -8 had a comple- 
ment-fixing titer of 1:4.  U.S.P. formaldehyde was added to the suspension  to a con- 
centration of 1 per cent (0.036 to 0.38 per cent formalin) by volume; after storage at 3°C. 
for 3 days, the pH of the suspension  was adjusted to about 8 by the addition of dilute 
ammonia water.  2 days later the reaction of the material was found to be slightly acid 
and it was readjusted to about pH 7.2, where it remained throughout the experiment. 
This treatment did not alter the complement-fixing activity of the preparation; further- 
more, administration of the material to guinea pigs caused no untoward effects. 
Each  of a  number of guinea pigs  was  injected  intraperitoneaUy with  formolized 
material at weekly intervals; certain groups received 1, 2, and 3 injections of 1 cc. each, 
while a fourth group was given 4 injections of 1.5 cc. each.  During the course of injec- 
tions these animals and those receiving soluble antigen were housed in a room by them- 
selves where strict  isolation precautions  were employed.  The guinea pigs  remained 
well; daily observations and temperature recordings  showed no signs of disease.  Serum 
taken from each animal 1 to 2 weeks after the final injection was titered for anti-soluble 
substance antibodies.  Sera from the groups of guinea pigs which had been injected 3 
and 4 times were also tested for the presence of neutralizing substances.  Finally, the 
animals were tested for immunity to a known amount of virus; 8 the groups receiving 1, 
2, and 3 immunizing injections were inoculated  1 week after the last dose,  while  the 
group receiving 4 injections was inoculated 2 weeks after the last injection.  At  this 
time the guinea pigs were moved from the isolation room to one which housed infected 
animals.  A summary of the data obtained in this experiment is presented in Table IV. 
From the results shown in Table IV, it is apparent that a  single injection 
of a  formolized non-infectious  suspension  of virus into normal guinea pigs 
neither  stimulated  the production  of anti-soluble  substance antibodies nor 
induced  immunity.  2  injections  of formolized  virus were followed by the 
development  of  complement-fixing  antibodies  and  by  some  resistance  to 
infection.  The  administration  of  3  doses  of material  induced  about  the 
same amount of anti-soluble  substance antibodies  as did 2 injections.  An 
increased  resistance  to  infection  was noted  in  the  guinea pigs receiving  3 
injections of vaccine; all of the animals survived, but 2  of  the 3  developed 
fever following  inoculation  of active  virus.  Neutralizing  substances  were 
not  demonstrable in  the  serum of these guinea  pigs.  Finally,  animals re- 
ceiving 4  injections  of formalin-treated  virus  suspension  were  solidly im- 
mune  to infection,  i.e.,  they remained afebrile and  survived when given a 
test  dose  3 of virus.  Moreover,  half  of the  guinea  pigs in  this group  had 
detectable  neutralizing  antibodies  in  their  serum  at  the  time  when  they 
were tested for immunity.  It is interesting  to note that the  complement- 
fixing fiters of the sera from these animals were lower on the average than 
those  displayed by guinea pigs receiving either 2  or 3  injections.  On  the 400  ANTIBODIES OF  LYMPHOCYTIC CHORIOMENINGITIS 
other hand, the injection of each of 9 guinea pigs with 7 cc. of a  formolized 
crude 10 per cent suspension of guinea pig spleen infected with one of several 
highly virulent  strains  of virus, including  the  W.  E.  strain,  has  not given 
results  similar  to  those  obtained  with  formolized  washed  virus.  Partial 
TABLE IV 
Response of Normal Guinea Pigs to Injections of Preparations of Formolized Washed Virus 
and of FormoIized Soluble Antigen 
Material injected  I  No. of 
injections  C-F titer 
l 
]  Negative 
] 
i  1:32 
2  1:32 
i  1:8 
Formol~ed  I 
[  1:16  washed  3  1:16 
virus  1:32 
4 
Formolized 
soluble 
antigen 
5 
Results of tests at end of injections 
1:8 
1:16 
1:8 
1:32 
1:32 
1:4 
Negative 
~c 
Neutralization test 
Immunity test 
Fever  Outcome 
Not done  +  D 
....  +  D 
"  "  +  D 
....  +  D 
"  "  +  S 
"  "  +  S 
Negative  +  S 
"  +  S 
cc  ~  S 
"  --  S 
c~  --  S 
cc  ~  S 
Positive  --  S 
~  --  S 
~c  ~  S 
Negative  +  D 
"  +  D 
"  +  D 
"  +  D 
"  +  D 
"  +  D 
Serum obtained from each animal before injections was negative in C-F test. 
See text for details of experiment. 
immunity developed in a few of the guinea pigs but complement-fixing anti- 
bodies were not  demonstrable. 
Response of Hyperimmune Guinea Pigs to a Single Injection of Soluble 
Antigen 
The preceding experiments might suggest that  the  so called soluble  an- 
tigen behaves as a hapten rather than as a true antigen since splenic extracts J.  E.  SMADEL  AND  M.  J.  WALL  401 
containing it  failed  to  elicit antibodies.  It  seemed desirable  to  test  in 
another way the antigenic properties of the complement-fixing substance by 
injecting preparations of it into guinea pigs which had recovered from a 
previous infection.  Thus, an anamnestic reaction might increase the anti- 
body response to  soluble antigen.  This was attempted in the following 
manner. 
10 guinea pigs which had been hyperimmunized with active virus several months 
previously were  found  to  possess complement-fixing antibodies in  low  titer,  ranging 
from  1:8  to  1:32.  Each of 5  of them was injected intraperitoneally with 3  cc.  of a 
TABLE  V 
Effect of FormoUzed Soluble Antigen and of Formolized Washed Virus on the Complement- 
Fixing Titer of Serum from Hyperimmune Guinea Pigs 
Material injected 
Formolized soluble 
antigen 
Formolized washed virus 
Guinea pig 
6 
7 
8 
9 
10 
C-F titer 
2 days before injection 
1:8 
1:8 
1:16 
1:16 
1:32 
1:8 
1:8 
1:16 
1:16 
1:32 
2 wks. after injection 
1:64 
1:256 
1:256 
1:512 
1:512 
1:32 
1:32 
1:64 
1:128 
1:64 
None of the animals developed fever after injection of either material. 
See text for details of experiment. 
formolized solution of antigen.  Each of the other 5, chosen to correspond with the first 
group in regard to the complement-fixing titer of their serum, was given 3 cc. of formo- 
lized ecirus suspension.  Both soluble antigen and virus were obtained from the same 
lot of spleens.  Sera collected 2 weeks after the single injection were tested for comple- 
ment-fixing activity. 
The results of the preceding experiment, summarized in Table V, show 
that in the guinea pigs which received the preparation of formolized soluble 
antigen,  the  titer  of  complement-fixing antibodies  increased  markedly.  4 
4 The injection of resting hyperimmune guinea pigs with a preparation of formolized 
soluble antigen has provided the simplest means so far available for regularly obtaining 
C-F serum of high titer.  In this connection, it might be mentioned that  reinjection 
of hyperimmune guinea pigs with repeated doses of several cc. of a  10 per cent crude 
suspension of guinea pig brain, rich in active virus, has provided a  successful but less 
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Moreover, animals which were given the suspension of formolized washed 
virus showed a considerable rise in titer of anti-soluble substance antibodies, 
but the increase was not so great as in the former group. 
DISCUSSION 
The present observations indicate that in lymphocytic choriomeningitis 
the  anti-soluble  substance  antibodies  and  neutralizing  antibodies  are 
entirely separate.  This was dearly shown by data obtained on the dif- 
ference in the time of appearance of the 2 types of antibody in human beings 
and in guinea pigs.  The anti-soluble substance antibodies appeared several 
weeks before neutralizing substances were detectable and diminished in a 
matter of months, whereas the neutralizing antibodies persisted for a much 
longer period of time.  The fact that mice developed anti-soluble substance 
antibodies but no demonstrable neutralizing substances adds weight to the 
concept that the 2 antibodies are distinct.  Additional evidence for the iden- 
tity of each type of antibody is drawn from the results of absorption experi- 
ments  already  reported  (3)  in  which  anti-soluble  substance  antibodies 
were removed from immune guinea pig serum by specific  soluble antigen 
contained in partially purified extracts of infected spleen.  Such absorbed 
sera were still capable of neutralizing the virus, but did not fix complement 
or precipitate in the presence of solutions of antigen. 
Howitt's data (19)  on the time of appearance of complement-fixing and 
neutralizing antibodies in  guinea  pigs  differ  from  ours.  A  possible  ex- 
planation of her failure to demonstrate complement fixation with certain 
sera may be  due to her use of preparations of infected brain  as antigen. 
Frequent attempts in  this laboratory  (2)  to  secure  consistently positive 
results with such preparations have been unsuccessful.  On the other hand, 
we  have  rarely  encountered negative results when a  solution of  splenic 
antigen was used in the complement-fixation test with serum from guinea 
pigs collected at least 3 weeks after infection with the virus.  This~is in 
contrast to the inability of L~pine, Mollaret, and Santter (21)  to demon- 
strate  the  presence  of  complement-fixing antibodies in  the  serum of  12 
guinea pigs after  infection with the virus.  These authors do not state, 
however, the time at which serum for testing was taken from guinea pigs 
or the severity of the induced disease; both of these factors are important. 
Data bearing on these points were given in the protocols of Experiments 1 
and 2.  Furthermore, the severity of the disease initiated by the W.  E. 
and 2 other strains of virus maintained in our laboratory is such that com- 
plement-fixing antibodies have  never been  demonstrated in  guinea pigs 
infected with them, because death invariably occurs before antibodies be- 
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When the results obtained with sera from animals, i.e.,  mice, rabbits, 
and particularly guinea pigs and monkeys, are compared with data on sera 
from human beings it is evident that the complement-fixing  titers of positive 
sera from human beings are rather low, since they range from 1:4 to 1:32. 
No explanation of this difference is at hand, but this finding agrees in a 
general way with the observation of L6pine,  Mollaret,  and Sautter  (21) 
who found that undiluted human serum taken some time after inoculation 
of active virus usually fixed 25 to 30 units of complement.  Only rarely did 
they obtain  a  high titer,  the maximum being fixation of  120  units with 
serum from a patient who had been reinoculated with the virus.  The low 
titer  of  complement-fixing antibodies in  serum from human beings with 
lymphocytic choriomeningitis and  the  fact  that  complement-fixing anti- 
bodies disappear comparatively early,  are in direct contrast to results of 
tests performed on serum from patients with psittacosis by Meyer and Eddie 
(29).  These workers showed that the titer  of such serum was as a  rule 
considerably higher than we have found in lymphocytic choriomeningitis, 
and that complement-fixing antibodies endured in a  number of instances 
for at least several years.  The existence of a  virus-carrier state has been 
suggested to account for the persistence of complement-fixing antibodies 
in patients after recovery from psittacosis (29). 
Results of the present experiments indicate that the production of anti- 
soluble substance antibodies of lymphocytic choriomeningitis can be elicited 
in guinea pigs by the administration of non-infectious material.  Although 
preparations of heated or formolized soluble antigen did not induce anti- 
bodies  in  normal  guinea  pigs,  the  latter  material  stimulated  a  marked 
response  in  immune animals  which had  small  amounts  of  complement- 
fixing substance in  their sera.  Furthermore, suspensions of washed for- 
molized virus were  capable  of inducing in  normal guinea  pigs not only 
complement-fixing antibodies, but also, under proper conditions, neutraliz- 
ing  substances  and  immunity to  infection.  Our  observations  on  neu- 
tralizing substances and immunity confirm and extend Traub's (27) experi- 
ments in which he obtained resistance to infection following injections of 
formolized crude tissue extracts made from infected organs.  A comparison 
of his data with ours suggests that formolized washed virus is a more etficient 
immunizing agent than is formolized crude tissue suspension. 
Traub (27) found that the addition of extracts of organs from a heterol- 
ogous species to formolized vaccine prepared from guinea pig tissue inter- 
fered with the response of guinea pigs to inactivated virus of lymphocytic 
choriomeningitis.  A  similar  finding has  been  reported  by  Laidlaw  and 
Dunkin (30) in connection with experiments on distemper vaccines and by 404  ANTIBODIES  OF  LYM~PHOCYTIC CHORIOMENINGITIS 
Andrewes and Smith (31) in descriptions of their work on influenza.  Non- 
specific interference by material consisting of formolized homologous tissue 
in  the  present experiments might possibly be  responsible  for  the  slight 
amount of resistance induced by injections of formolized crude tissue sus- 
pension when compared with the definite immunity produced by formolized 
washed  virus.  In  this  connection  Hartley's  (32)  observation  may  be 
mentioned, namely, that the addition of extracts of guinea pig muscle to 
flocculated mixtures of diphtheria toxin-antitoxin interfered to some extent 
with the  antigenic response of guinea pigs receiving the material.  One 
might be  tempted to extend the idea of interference to  account for  the 
failure of normal guinea pigs to respond to the comparatively small amounts 
of soluble antigen, when contrasted to  the  amount of tissue protein, in 
formolized  virus-free  splenic  extracts.  The  presence  of  even  smaller 
amounts of the  antigen in  preparations  of inactivated washed  virus,  as 
demonstrated by  an in  vitro  technique, viz.,  complement fixation, might 
nevertheless be sufficient to elicit complement-fixing antibodies in normal 
guinea pigs because of the presence of relatively small quantities of material 
antigenically unrelated to the virus, and because of the fact that most sub- 
stances when adsorbed on the surface of particles develop enhanced anti- 
genic properties.  At least some foundation for such an idea may be found 
in the experiments with formolized crude suspensions of spleen in which no 
production of complement-fixing  antibodies was detectable in pigs receiving 
such  suspensions. 
CONCLUSIONS 
Anti-soluble  substance  antibodies  and  neutralizing  substances,  which 
develop following infection with the virus of lymphocytic choriomeningitis, 
appear to be separate entities.  The times of appearance and regression of 
the two antibodies are different in both man and the guinea pig; the anti- 
soluble substance  antibodies appear earlier  and  remain  a  shorter  time. 
Moreover, mice develop them but no demonstrable neutralizing substances. 
Injection of formalin-treated, virus-free extracts containing considerable 
amounts of soluble antigen fails to elicit anti-soluble substance antibodies 
and to induce immunity in normal guinea pigs; administration of such prep- 
arations to immune pigs, however, is followed by a marked increase in the 
titer  of anti-soluble  substance  antibodies in  their  serum.  On  the  other 
hand, suspensions of formolized washed virus are effective in normal guinea 
pigs in stimulating both anti-soluble substance antibodies and protective 
substances, and in inducing immunity to infection. J.  E.  SMADF,  L  AND  M.  j.  WALL  405 
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